Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 0 CBD trial in recurrent glioblastoma
NL-OMON59827Phase 1Recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of cannabidiol in glioblastoma (GBM), sponsored by Erasmus MC. Started Aug 2025; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NL-OMON59827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59827.